Hologic, Inc. (Nasdaq: HOLX) announced today that it has priced and allocated its previously announced private offering of $1 billion in aggregate principal amount of senior notes as follows: (i) $600 million aggregate principal amount of additional 4.375% senior notes due 2025 at an issue price of $1,000 per $1,000 and (ii) $400 million aggregate principal amount of 4.625% senior notes due 2028 at an issue price of $1,000 per $1,000.

The additional 2025 notes will be issued under the indenture dated October 10, 2017 that governs Hologic's 4.375% senior notes due 2025 dated October 10, 2017. The new 2028 notes will be issued pursuant to a new indenture to be executed as of the closing of the offering. The offering of the new 2028 notes and the additional 2025 notes is expected to close on January 19, 2018, subject to customary closing conditions.

Hologic intends to use the net proceeds of the offering and available cash, which may include funds from its secured revolving credit facility, to redeem its outstanding 5.25% senior notes due 2022 in the aggregate original principal amount of $1.0 billion.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.